1. Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance
   S. Inder et al, 2019, Sci Rep CrossRef
2. Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer
   Caroline N. Barquilha et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
3. Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression In Vivo and In Vitro
   Se-Yun Cheon et al, 2020, J. Nat. Prod. CrossRef
4. FOXO transcription factor family in cancer and metastasis
   Yannasittha Jiramongkol et al, 2020, Cancer Metastasis Rev CrossRef
5. Advances in Targeting Cancer-Associated Genes by Designed siRNA in Prostate Cancer
   Amirhossein Bahreyni et al, 2020, Cancers CrossRef
6. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
   Joshua Altschuler et al, 2021, IJMS CrossRef
7. Inhibition of PARP1 Dampens Pseudorabies Virus Infection through DNA Damage-Induced Antiviral Innate Immunity
   Guo-Li Li et al, 2021, J Virol CrossRef
8. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
   Sepideh Mirzaei et al, 2021, Cells CrossRef
9. DNA Damage Response and Cancer Metastasis: Clinical Implications and Therapeutic Opportunities
   Ming Yin et al, 2022 CrossRef